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Abstract
Background: There is limited information about the epidemiology of influenza in Africa. We describe the epidemiology and
seasonality of influenza in Morocco from 1996 to 2009 with particular emphasis on the 2007–2008 and 2008–2009 influenza
seasons. Successes and challenges of the enhanced surveillance system introduced in 2007 are also discussed.
Methods: Virologic sentinel surveillance for influenza virus was initiated in Morocco in 1996 using a network of private
practitioners that collected oro-pharyngeal and naso-pharyngeal swabs from outpatients presenting with influenza-like-
illness (ILI). The surveillance network expanded over the years to include inpatients presenting with severe acute respiratory
illness (SARI) at hospitals and syndromic surveillance for ILI and acute respiratory infection (ARI). Respiratory samples and
structured questionnaires were collected from eligible patients, and samples were tested by immunofluorescence assays
and by viral isolation for influenza viruses.
Results: We obtained a total of 6465 respiratory specimens during 1996 to 2009, of which, 3102 were collected during
2007–2009. Of those, 2249 (72%) were from patients with ILI, and 853 (27%) were from patients with SARI. Among the 3,102
patients, 98 (3%) had laboratory-confirmed influenza, of whom, 85 (87%) had ILI and 13 (13%) had SARI. Among ILI patients,
the highest proportion of laboratory-confirmed influenza occurred in children less than 5 years of age (3/169; 2% during
2007–2008 and 23/271; 9% during 2008–2009) and patients 25–59 years of age (8/440; 2% during 2007–2009 and 21/483;
4% during 2008–2009). All SARI patients with influenza were less than 14 years of age. During all surveillance years, influenza
virus circulation was seasonal with peak circulation during the winter months of October through April.
Conclusion: Influenza results in both mild and severe respiratory infections in Morocco, and accounted for a large
proportion of all hospitalizations for severe respiratory illness among children 5 years of age and younger.
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Introduction
Since 1948, the World Health Organization (WHO) Global
Influenza Surveillance Network has provided a platform to
monitor circulating influenza types and subtypes to make informed
decisions about the composition of influenza vaccine [1]. In 2001,
the WHO formulated a Global Agenda for Influenza Surveillance
and Control which highlighted priority strategies to reduce
morbidity and mortality from annual influenza epidemics and
prepare for influenza pandemics. These strategies include:
strengthening surveillance, improving knowledge of burden of
influenza, increasing vaccine usage, and accelerating pandemic
preparedness [2]. Influenza sentinel surveillance, which includes
the collection of epidemiological and virological data, provides a
tool to monitor the circulating types and subtypes of influenza to
assess the burden of influenza in the community and to rapidly
detect the appearance of novel influenza subtypes in the human
population. These data can be used to understand geographic,
temporal, and biologic differences in circulating influenza strains
and to monitor for the emergence and evolution of pandemic
strains [3–5].
The prevalence and burden of influenza are well documented in
the temperate countries of the northern and southern hemispheres
[5–13]. In contrast much less is known about the epidemiology,
burden and patterns of transmission of influenza in tropical
countries and even less in the African continent. A recent
systematic review of available data from Africa emphasized that
data from Africa are insufficient to allow most countries to
prioritize strategies for influenza prevention and control [14,15].
Identified data gaps in Africa include temporal patterns of
influenza virus circulation, the incidence of influenza-associated
outpatient visits, hospitalizations, and mortality for all ages, and
the contribution of influenza to the overall burden of respiratory
illness hospitalizations among adults and children. In Morocco,
influenza sentinel surveillance was established in 1996 [16] and
was expanded starting in 2007 in response to the emergence of the
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influenza surveillance data from Morocco from 1996–2009, we
describe the seasonality of influenza virus circulation, identify age
groups accounting for a large proportion of influenza-associated
outpatient visits and hospitalizations, and discuss the successes and
challenges of expanding influenza surveillance during 2007–2009.
Methods
Study design and setting
Morocco is located in the temperate zone of Northern Africa
and encompasses Atlantic and Mediterranean coast lines as well as
mountainous and desert areas. The country is divided into 16
administrative regions and 81 prefectures and provinces. Each
administrative region has a tertiary care regional referral hospital
that is linked to provincial hospitals and in turn to the nationwide
system of health centers. Health care in Morocco is provided by
public hospitals and health centers as well as private clinics.
Though people may utilize medical services in either sector, in
general, medical services provided through the public sector are
less expensive than those provided through the private sector.
According to the 2007 statistics of the Ministry of Health of
Morocco, approximately 50% of the population receives health
care through the public sector [17]. Influenza vaccine is not
provided by the public sector. However, seasonal influenza
vaccine is available from private pharmacies.
Influenza sentinel surveillance during 1996–2003
During 1996–2003, the National Influenza Center (NIC)
situated at the National Institute of Hygiene conducted virological
surveillance using a network of volunteer private practitioners that
identified patients with influenza-like illness (ILI) or acute
respiratory illness (ARI) from patients presenting at the sentinel
clinics and collected specimens for influenza testing and basic
demographic data from a subset of patients with ILI each year
during October through April. ILI was defined as an outpatient
with fever ($38uC) and cough or sore throat with onset less than
five days prior to presentation in the absence of a specific
diagnosis. ARI was defined as an outpatient with sudden onset of
respiratory signs including cough, difficulty breathing, rhinitis or
coryza and general symptoms such as fever, headache, fatigue, and
myalgia less than five days prior to presentation.
Influenza sentinel surveillance during 2004–2006
In 2004, the Epidemiology Department at the Ministry of
Health expanded the existing system through the implementation
of syndromic surveillance for ARI and ILI in the 16 administrative
regions of the country using a network of 375 public clinics
covering all provinces and prefectures and a population of 12
million people. Aggregated numbers of ARI and ILI cases were
collected.
Influenza sentinel surveillance during 2007–2009
Starting in 2007, the system was further enhanced through the
collection of virological and epidemiological data from both the
private practitioner and public clinic networks. One health centre
in each region collected samples from the first 5 ILI cases
identified each day. In addition, the 110 private practitioners
participating in the virological sentinel surveillance network began
providing clinical and demographic data for all ARI and ILI cases
during October to April and began reporting the total number of
consultations by week.
Furthermore, surveillance for severe acute respiratory illness
(SARI) was established in 14 of the 16 regions of the country. In
patients five years of age and older, SARI was defined as a
hospitalized patient with fever (.38uC), cough, and shortness of
breath or difficulty breathing with duration of illness less than
seven days. In patients two months through five years of age, SARI
was defined as a child hospitalized for cough or difficulty
breathing, with or without wheezing and stridor in a calm child,
or chest indrawing. In patients 1 week through 2 months of age,
SARI was defined as hospitalization for a respiratory illness
associated with one of the following signs: convulsions, rapid
breathing ($60 breaths per minute in a calm infant), chest
indrawing, nasal flaring, grunting, lethargy or unconsciousness,
decreased movement, fever (.38uC or warm to touch), or
hypothermia (,36uC or cold to the touch). SARI cases were
identified from patients hospitalized in the pediatrics, pneumonol-
ogy, and internal medicine units in the 14 regional hospitals. All
SARI cases were eligible for enrollment. Data on gender, age,
clinical symptoms, treatment, influenza vaccination status and
travel history in the 7 days prior to symptom onset were collected
from all ILI and SARI patients that were enrolled in the
virological surveillance system using a standard case report form.
During 2007–2008, a laboratory network of 14 regional
laboratories supervised by the NIC was established. Two
additional laboratories joined the network during 2009–2010.
Human Subjects Review
All surveillance protocols were reviewed and approved by the
Ethic Committee of the Morocco Ministry of Health.
Sample collection and laboratory procedures
During 1996–2009, oro-pharyngeal and naso-pharyngeal swabs
were collected from ILI and SARI patients enrolled under the
virological surveillance system and placed in cryovials containing
2 ml of virus transport medium. Oro-pharyngeal and naso-
pharyngeal swabs collected from the same patient were placed
in one cryovial, stored at 4uC at the sentinel site, and transported
daily to the NIC or the Regional Reference Laboratories. For
transportation, the specimens were packaged using a standard
triple packaging system at the sentinel sites and were transported
in cool boxes.
Until 2007, all ILI samples collected under the public and
private sentinel surveillance network were sent to the NIC for
testing. Starting in 2007, SARI and ILI samples collected under
the public sentinel surveillance network were sent to the Regional
Reference Laboratories. All specimens were tested for influenza A
and B viruses, adenovirus, parainfluenza 1–3 and respiratory
syncytial virus using commercial indirect immunofluorescence kits
(VRK Bartels). All SARI samples and influenza-positive ILI
samples were further sent to the NIC for confirmation of influenza
results by virus isolation using Madin Darby Canine Kidney
(MDCK) cell lines and haemagglutination inhibition assay for
typing and subtyping of positive influenza samples using the
standardized WHO reagents and protocols. Specimens collected
from ILI cases identified by private practitioners were sent directly
to the NIC during the entire period (1996–2007). The national
postal service was responsible for the delivery of samples.
Data management and analysis
Prior to 2007, data were entered by surveillance collaborators
into an EpiInfo database (Version 6). Starting in 2007, a web-
based integrated database (grippe.sante.gov.ma/INH) was used for
data storage and sharing.
Influenza seasonality was compared with ILI and ARI temporal
patterns from 1996 to 2009. Frequencies were calculated for
demographics and clinical characteristics of patients with ILI and
Influenza Surveillance in Morocco, 1996–2009
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24579SARI with influenza during 2007–2009. During the 2008–2009
season, the monthly burden of outpatient consultations for
influenza was estimated using data from public and private






Interrupted Time Series Analysis (ITSA) was used to assess the
impact (expressed as improvement of case detection) of the
enhanced surveillance system introduced in 2007. For this, we
used a segmented stepwise linear regression model that allows the
partition of a time series into pre- and post-intervention segments
[18,19] using the year 2007 as the cut-off point. The constants
(level) and slopes of the pre- and post-intervention regression
models were used to assess the changes in performance of the
system at the beginning of each period (constant) and the changes
in trends over the two periods (slope). The following model was
used for the analysis:
Yt~b0zb1Ttzb2Itzb3TAItzet ð1Þ
Where:
N Yt: is the dependent variable in the model (number of samples)
N b0: estimates the baseline level of Yt at the beginning of the
time series (the beginning of the influenza surveillance in
Morocco in 1996)
N b1: estimates the trend of Yt during the pre-intervention period.
N Tt: is a continuous variable indicating the time in years at time
t from the start of the surveillance period.
N b2: estimates the change in baseline level after the intervention
N It: is a dummy variable that defines the pre- (0) and post-
intervention (1) period.
N b3: estimates the change in the slope from pre- to the post-
intervention period
N TAIt: is a continuous variable indicating the number of years
after the start of the intervention at time t.
N et: is the error term of the model.
Only predictors significant at a.0.05 were included in the final
model. The analysis was implemented using SPSS 18.
Results
Influenza surveillance, 2007–2009
During the 2007–2008 and 2008–2009 seasons, 3102 specimens
were collected from patients at sentinel sites. Of those, 2249 (73%)
were from patients with ILI, and 853 (27%) were from patients
with SARI. Among the ILI patients, 1371 (61%) were identified by
the private sentinel network, and 878 (39%) by the public sentinel
clinics. Patients 25–59 years of age accounted for the highest
proportion of ILI cases during both seasons (44% during 2007–
2008 and 39% during 2008–09). Among the SARI cases, children
less than 5 years of age accounted for 86% of cases during 2007–
2008 and 79% of cases during 2008–2009. Three percent (39/
1400) of cases had received influenza vaccine during 2007–08, and
4% (66/1702) had received influenza vaccine during 2008–09
(Table 1).
Of the 3102 enrolled patients, 98 (3%) had laboratory-
confirmed influenza, of whom, 85 (87%) were ILI patients, and
13 (13%) were SARI patients. Among ILI patients, the proportion
of laboratory-confirmed influenza cases was highest in children less
than 5 years of age (3/169; 2% in 2007–2008 and 23/271; 9% in
2008–2009) and patients 25–59 years of age (8/440; 2% in 2007–
2009 and 21/483; 4% in 2008–2009). All SARI patients with
influenza were 14 years of age or younger (Table 2). The median
length of time from symptom onset to testing was 3 days for SARI
cases less than 14 years of age and 4 days for those 15 years of age
and over during the 2007–08 season, and 5 days for both age
groups during the 2008–09 season.
Influenza virus circulation and seasonality
During 2007–2008, influenza A(H1N1) (5/19; 26%) and B (14/
19; 74%) (Yamagata and Victoria lineages) were detected from
specimens taken from ILI and SARI patients; during 2008–2009,
influenza A(H1N1) (39/79; 49%), A(H3N2) (30/79; 38%) and B
(10/79; 13%) (Victoria lineage) were detected. Twenty-nine
specimens tested positive for viruses other than influenza
including: RSV (25/29; 86%), adenovirus (2/29; 7%), and
parainfluenza viruses (2/29; 7%).
During the 2007–2008 influenza season, influenza viruses were
isolated from week 49/07 (December 3–9, 2007) to week 13/08
Table 1. Demographic characteristics of influenza-like illness
(ILI) and severe acute respiratory illness (SARI) patients,
Morocco, 2007–2009.
Season 2007–08* 2008–09**
ILI surveillance N=997 N=1252
n( % ) n( % )
Network
Private network 559 (40) 812 (48)
Health units network 438 (31) 440 (26)
Age
,5 year 169 (17) 271 (22)
5–14 year 136 (14) 177 (14)
15–24 year 167 (17) 216 (17)
25–59 year 440 (44) 483 (39)
.60 year 85 (9) 105 (8)
Gender
Male 488 (49) 589 (47)
Influenza Vaccination 30 (3) 53 (4)
SARI surveillance N=403 N=450
n( % ) n( % )
Hospitals network 403 (29) 450 (26)
Age
,5 year 345 (86) 351 (78)
5–14 year 27 (7) 38 (8)
15–24 year 10 (2) 22 (5)
25–59 year 20 (5) 26 (6)
.60 year 1 (,1) 13 (3)
Gender
Male 255 (63) 261 (58)
Influenza Vaccination 9 (2) 13 (3)
*from September 2007 to August 2008.
**from September 2008 to August 2009.
doi:10.1371/journal.pone.0024579.t001
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(January 14–27, 2008). During the 2008–2009 influenza season,
influenza viruses were detected from week 43/08 (October 20–26,
2008) to week 16/09 (April 13–19, 2009) and peaked during weeks
1/09 and 2/09 (December 29, 2008–January 11, 2009).
The total number of ILI cases and total number of consultation
were available from the public health unit network for 2007–2009
and from the private network for 2008–2009. The proportion of
ILI cases over total number of consultations in both the public
health units and private networks increased concomitantly with
the circulation of influenza viruses (Figure 1). During the 2008–
2009 influenza season, the estimated monthly proportion of all
patient consultations in the private network that was associated
with laboratory-confirmed influenza began to increase during the
month of November (0.6%) and peaked in January (1.3%). A
similar pattern was observed in the public sector where the
proportion of all patient consultations associated with laboratory-
confirmed influenza began to increase in December (0.03%) and
January (0.05%), peaked in February (0.1%), and declined to
baseline levels in March (0%).
During 1996–2007, the NIC received a total of 3363 specimens
with a minimum of 94 specimens during the 2000–2001 season
and a maximum of 634 specimens during the 2004–2005 season.
During the entire surveillance period (1996–2009), influenza
viruses were isolated from October to March, although the period
of peak influenza virus circulation varied across seasons (Figure 2).
Assessment of the enhanced surveillance system
During 1996–2006, preceding the introduction of the enhanced
influenza surveillance, the estimated average number of additional
samples for each consecutive season was 33 (e.g. 33 more samples
expected on average from one season to the next). After 2007
when the enhanced surveillance system was implemented, the
estimated average number of additional samples for each
consecutive season was 623 (Table 3). If the enhanced surveillance
system had not been implemented, the expected total number of
samples for the 2008/09 season would have been 541 (Figure 3).
The 1702 samples collected in the 2008–2009 season represent a
215% increase in the total number of samples compared with the
number expected in the same season if the surveillance system
remained the same (541).
Discussion
We described the epidemiology and seasonality of influenza in
Morocco using influenza surveillance data from 1996 to 2009. We
found that influenza viruses affected all age groups and circulated
seasonally during the Moroccan winter months of October
through April with peak circulation occurring frequently in
December, similar to patterns documented in the temperate
regions of the Northern hemisphere [10–13]. In addition we found
that influenza accounted for 4%–9% of hospitalizations for SARI.
Children less than five years of age accounted for more than two
thirds of all patients hospitalized with severe acute respiratory
illness at sentinel sites in Morocco, and 1% of SARI patients in this
age group had laboratory-confirmed influenza. Our findings
contribute to the growing literature documenting that young
children are at increased risk for severe respiratory infection, and
that influenza contributes to the burden of severe respiratory
infection in young children globally [20–22]. Both the burden of
severe respiratory infection and the proportion due to viral
etiologies including influenza are largely undocumented in Africa
highlighting the need for continued development of respiratory
illness surveillance in Africa. [14,15]
Although influenza sentinel surveillance has been ongoing in
Morocco since 1996, the enhancement of the surveillance system
Table 2. Proportion of patients with laboratory-confirmed influenza by age group and surveillance network, Morocco, 2007–2009.
Season 2007–08* 2008–09**
ILI surveillance n/N (%) 95% CI (%) n/N (%) 95% CI (%)
Network
Private network 6/559(1.07) 0.39–2.32 64/812 (7.88) 6.12–9.95
Health units network 9/438 (2.05) 0.94–3.86 6/440 (1.36) 0.50–2.94
Age
,5 year 3/169 (1.78) 0.37–5.09 23/271 (8,49) 5.46–12.46
5–14 year 2/136 (1,47) 0.18–5.21 10/177 (5,65) 2.74–10.14
15–24 year 1/167 (0,59) 0.00–3.29 12/216 (5,56) 2.90–9.50
25–59 year 8/440 (1.82) 0.79–3.55 21/483 (4,35) 2.71–6.57
.60 year 1/85 (1,18) 0.03–6.38 4/105 (3.81) 1.05–9.47
SARI surveillance n/N (%) 95% CI (%) n/N (%) 95% CI (%)
Hospitals network 4/403 (0.99) 0.27–2.52 9/450 (2.00) 0.92–3.76
Age
,5 year 1/345 (0,29)) 0.00–1.60 8/351 (2,28) 0.99–4.44
5–14 year 3/27 (11.11) 2.35–29.16 1/38 (2,63) 0.07–13.81
15–24 year 0/10 (0.00) 0.00–30.85 0/22 (0.00) 00.00–15.44
25–59 year 0/20 (0.00) 00.00–16.84 0/26 (0.00) 00.00–13.23
.60 year 0/1 (0.00) 0.00–97.50 0/13 (0.00) 00.00–24.70
*from September 2007 to August 2008.
**from September 2008 to August 2009.
doi:10.1371/journal.pone.0024579.t002
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health unit and private clinic networks by week, Morocco, 2007–2009.
doi:10.1371/journal.pone.0024579.g001
Figure 2. Onset peak and duration of influenza seasons, Morocco, 1996–2009.
doi:10.1371/journal.pone.0024579.g002
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substantially increased the number of respiratory specimens
obtained from the system. In addition, the enhanced surveillance
system permitted to estimate the rates of influenza infection
requiring medical care and the burden of influenza on outpatient
consultations and inpatient admissions.
Prior to 2007, the burden of influenza-associated consultations
on private practitioners in Morocco was unknown. Through
expansion of syndromic influenza surveillance to include the
private sector in Morocco, we found that ILI and ARI
consultations accounted for a larger proportion of all consultations
seen in the private sector than in the public sector, highlighting the
importance of engaging private practitioners in respiratory illness
surveillance when feasible in communities that utilize private
practitioners for acute medical care.
Despite the importance of these preliminary results, our
surveillance system has limitations. Despite the increased number
of samples obtained under the enhanced surveillance system, the
rate of influenza virus detection remains low. The enhanced
surveillance system in Morocco is relatively new; thus, participat-
ing clinicians may not have correctly identified all ILI or SARI
cases, and specimen collection and storage techniques may not
always have been optimal. In addition, the identification of
influenza viruses was performed primarily using immunofluores-
cence assays which are less sensitive for the detection of influenza
viruses than viral culture and real time reverse transcriptase
polymerase chain reaction assays (rRT-PCR). The limited number
of samples obtained during the initial years of surveillance
hindered the use of time series analysis to statistically identify
seasonal trends.
Figure 3. Observed and predicted (using the Interrupted Time Series Analysis) numbers of samples during the pre- and post-
intervention period, Morocco, 1996–2009.
doi:10.1371/journal.pone.0024579.g003
Table 3. Model coefficient, 95% confidence interval and p-value for the Interrupted Time-Series Regression Analysis for the
assessment of the impact of the enhanced surveillance system, Morocco, 1996–2009.
Parameter Coefficients 95% CI p
Constant (at the beginning of the surveillance system: 1996) 68.1 2127.4–263.6 0.459
Time (during the pre-intervention period)* 33.8 7.5–59.9 0.016
Time (during the post-intervention period)** 623.4 434.0–812.7 ,0.001
*the slope coefficient represent the expected average increase of number of samples in each consecutive year during the pre-intervention period (1996–2006).
**the slope coefficient represent the expected average increase of number of samples in each consecutive year during the post intervention period (2007–2009).
doi:10.1371/journal.pone.0024579.t003
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24579In conclusion, we document that influenza is responsible for
both mild and severe respiratory illness in Morocco. A large
majority of hospitalizations for SARI occur in children five years
of age and under. During 1996–2009, the Moroccan influenza
sentinel surveillance system generated important baseline data on
respiratory illness and the proportion attributable to influenza;
these data could be used to inform future evaluations of the impact
of influenza prevention programs.
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